Abstract
If the current generation of artemisinin-based combination therapies should fail, does the world have a solid backup plan? The short answer: No.
Publisher
American Association for the Advancement of Science (AAAS)
Cited by
22 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献